We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.55B
AUM Growth
+$122M
Cap. Flow
+$6.03M
Cap. Flow %
0.39%
Top 10 Hldgs %
31.79%
Holding
214
New
9
Increased
74
Reduced
70
Closed
7

Top Sells

Rank Stock Value
1
BC icon
Brunswick
BC
+$3.32M
2
MSFT icon
Microsoft
MSFT
+$3M
3
FDX icon
FedEx
FDX
+$1.86M
4
EBAY icon
eBay
EBAY
+$997K
5
SNPS icon
Synopsys
SNPS
+$941K

Sector Composition

Rank Sector Weight
1 Technology 30.41%
2 Healthcare 14.16%
3 Industrials 12.9%
4 Financials 11.51%
5 Consumer Staples 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAT icon
101
Waters Corp
WAT
$37.7B
$1.08M 0.07%
2,910
J icon
102
Jacobs Solutions
J
$16.6B
$1M 0.06%
8,670
+195
+2% +$22.5K
MCD icon
103
McDonald's
MCD
$194B
$1M 0.06%
3,746
-77
-2% -$19.4K
FUL icon
104
H.B. Fuller
FUL
$3.07B
$980K 0.06%
12,094
VEU icon
105
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$960K 0.06%
15,694
CTRA
106
DELISTED
Coterra Energy
CTRA
$950K 0.06%
50,104
WST icon
107
West Pharmaceutical
WST
$23.7B
$950K 0.06%
2,018
GE icon
108
GE Aerospace
GE
$377B
$940K 0.06%
15,993
-342
-2% -$21.5K
VPL icon
109
Vanguard FTSE Pacific ETF
VPL
$7.89B
$920K 0.06%
11,825
NEE icon
110
NextEra Energy
NEE
$186B
$910K 0.06%
9,728
-52
-0.5% -$4.49K
PM icon
111
Philip Morris
PM
$312B
$910K 0.06%
9,560
-1
-0% -$93
LLY icon
112
Eli Lilly
LLY
$1.09T
$850K 0.05%
3,071
IONS icon
113
Ionis Pharmaceuticals
IONS
$9.14B
$810K 0.05%
26,771
+5,080
+23% +$160K
JWN
114
DELISTED
Nordstrom
JWN
$810K 0.05%
35,720
-2,315
-6% -$61.3K
VHT icon
115
Vanguard Health Care ETF
VHT
$18.6B
$810K 0.05%
3,045
AZN icon
116
AstraZeneca
AZN
$267B
$790K 0.05%
6,779
-356
-5% -$41.9K
BDX icon
117
Becton Dickinson
BDX
$45.8B
$790K 0.05%
3,226
+99
+3% +$23.7K
NVO
118
Novo Nordisk
NVO
$225B
$750K 0.05%
13,434
CMCSA icon
119
Comcast
CMCSA
$85.8B
$730K 0.05%
14,574
-529
-4% -$27.6K
ABBV icon
120
AbbVie
ABBV
$465B
$690K 0.04%
5,097
-486
-9% -$57.4K
DD icon
121
DuPont de Nemours
DD
$19B
$680K 0.04%
6,681
HUBB icon
122
Hubbell
HUBB
$25.6B
$680K 0.04%
3,275
-33
-1% -$6.6K
CSCO icon
123
Cisco
CSCO
$456B
$640K 0.04%
10,081
-305
-3% -$17.4K
IBM icon
124
IBM
IBM
$214B
$640K 0.04%
4,786
-325
-6% -$40.8K
BP icon
125
BP
BP
$107B
$630K 0.04%
23,479

Similar funds

Grandfield & Dodd's Q4 2021 Portfolio in Review

As of Q4 2021, Grandfield & Dodd held 214 positions worth $1.55B, up 8.5% from $1.43B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Grandfield & Dodd's Q4 2021 filing shows 9 new, 74 increased, 70 reduced and 7 closed positions. Its largest new stake was People Inc: 14,217 shares worth $1.52M. The largest sale was Brunswick, an estimated $3.32M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

  • Grandfield & Dodd's largest Q4 2021 buy was People Inc: 14,217 shares worth $1.52M.
  • Grandfield & Dodd added most to AutoZone in Q4 2021, an estimated $2.5M increase.
  • Grandfield & Dodd's biggest Q4 2021 reduction was Brunswick, cutting an estimated $3.32M.
  • Grandfield & Dodd fully exited Emcor in Q4 2021, selling an estimated $270K.
  • Grandfield & Dodd's ten largest holdings make up 32% of its $1.55B portfolio in Q4 2021.
  • Grandfield & Dodd opened 9 new positions and closed 7 in Q4 2021.
  • Grandfield & Dodd's portfolio value rose 8.5% quarter-over-quarter to $1.55B.

Based on Grandfield & Dodd's 13F filing for Q4 2021, filed 8 Feb 2022.